Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $106.2400 (-0.89%) ($106.2400 - $106.2400) on Fri. Jan. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.02% (three month average) | RSI | 59 | Latest Price | $106.2400(-0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND advances 0.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(51%) IWC(50%) | Factors Impacting LGND price | LGND will decline at least -1.51% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.51% (StdDev 3.02%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $103.28(2.87%) | 10 Day Moving Average | $102.76(3.39%) | 20 Day Moving Average | $100.94(5.25%) | To recent high | -0.9% | To recent low | 32.2% | Market Cap | $1.707b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |